Grant: CIHR Fellowship
Direct Payment
$116,667.00
The role of matrix metalloproteinase 12 in trophoblast-directed uterine vascular remodeling
EF 2010-11
Résumé
Preeclampsia and fetal growth restriction (FGR) are leading causes of hospitalization, preterm birth, and death in pregnant mothers and their babies in Canada and worldwide. A recent Canadian Institutes of Health Information survey found that babies born small for gestational age or preterm, constituting 1 in 7 births in Canada, had hospitalization stays up to twelve weeks longer than normal births, costing up to $107,000 more in health care costs per birth. Moreover, babies born from these complicated pregnancies often exhibit significant physical and cognitive disabilities and chronic health problems later in life. Therefore, studying the causes of preeclampsia and FGR is of utmost importance. The primary pathologic feature of preeclampsia and FGR is reduced blood flow through the uterine blood vessels that supply the placenta. Normally, placental cells migrate into the uterus and actively cause expansion of uterine blood vessels to increase blood flow to the placenta. In particular, expansion is mediated by breaking down the elastic layer surrounding the blood vessels. Our lab and others have recently identified abundant and specific expression of matrix metalloproteinase 12 (MMP12), an enzyme with potent and specific elastase activity, within migrating placental cells. However, the regulation of this protease in migrating placental cells, as well as the biological significance of its expression, is unclear. Therefore, using in vitro and in vivo models, we will determine the role of MMP12 in placental cell-mediated expansion of uterine blood vessels. This project will have important diagnostic and therapeutic implications for women's and children's health, which is certainly within the goals of the CIHR.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Kansas, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
225861
Name
Renaud Stephen J
Region
Kansas
Country
United States of America
Orgtype
Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The role of matrix metalloproteinase 12 in trophoblast-directed uterine vascular remodeling
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$116,667
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cellular Invasion; Focal Adhesion Kinase; In Vitro Cell Models; In Vivo Lentiviral Gene Transfer; Placenta; Pregnancy; Trophoblast; Vascular Remodelling
Abstract
Preeclampsia and fetal growth restriction (FGR) are leading causes of hospitalization, preterm birth, and death in pregnant mothers and their babies in Canada and worldwide. A recent Canadian Institutes of Health Information survey found that babies born small for gestational age or preterm, constituting 1 in 7 births in Canada, had hospitalization stays up to twelve weeks longer than normal births, costing up to $107,000 more in health care costs per birth. Moreover, babies born from these complicated pregnancies often exhibit significant physical and cognitive disabilities and chronic health problems later in life. Therefore, studying the causes of preeclampsia and FGR is of utmost importance. The primary pathologic feature of preeclampsia and FGR is reduced blood flow through the uterine blood vessels that supply the placenta. Normally, placental cells migrate into the uterus and actively cause expansion of uterine blood vessels to increase blood flow to the placenta. In particular, expansion is mediated by breaking down the elastic layer surrounding the blood vessels. Our lab and others have recently identified abundant and specific expression of matrix metalloproteinase 12 (MMP12), an enzyme with potent and specific elastase activity, within migrating placental cells. However, the regulation of this protease in migrating placental cells, as well as the biological significance of its expression, is unclear. Therefore, using in vitro and in vivo models, we will determine the role of MMP12 in placental cell-mediated expansion of uterine blood vessels. This project will have important diagnostic and therapeutic implications for women's and children's health, which is certainly within the goals of the CIHR.
Competitiondate
201102
Approvedterm2
2 yrs 4 mths
Pinamesdelim
Renaud, Stephen J
Approvedterm
2 ans 4 mois
Cihrcontribution2
~ $116,667~ $0~